Advertisement

Genetics of Vas Aplasia

  • Rahul Krishnaji Gajbhiye
  • Shagufta Khan
  • Rupin Shah
Chapter
  • 64 Downloads

Abstract

Congenital bilateral absence of the vas deferens (CBAVD) involves a complete or partial defect of the Wolffian duct derivatives and is a common cause of obstructive azoospermia. There are different subphenotypes of CAVD such as congenital bilateral absence of vas deferens (CBAVD), congenital unilateral absence of vas deferens (CUAVD), and CBAVD/CUAVD associated with renal anomalies. 95% of men with cystic fibrosis have CBAVD, while 60–70% of men with isolated CBAVD have detectable mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Failure to detect a CFTR abnormality in these men could be due to limitations of the mutation detection methods or due to an etiology other than CFTR gene. The CFTR mutations have been traditionally classified into six classes based on clinical severity of CFTR mutations. Majority of CBAVD men have one severe and one mild CFTR mutation or two mild CFTR mutations. A proportion of CBAVD men (11–20%) suffer from concomitant urogenital abnormalities. CFTR mutations are generally not detected in these men, and other genetic causes are postulated. The type and severity of mutation vary with geography and ethnicity. Current ASRM, ACOG, and ACMG recommendations for genetic diagnosis or risk prediction of CBAVD have limitations, and there is a need to develop regional guidelines based on the ethnic-specific CFTR mutation screening. We describe the clinical presentation, diagnosis, and CFTR abnormalities detected in different subphenotypes of CAVD.

Keywords

Vas aplasia Genetics Cystic fibrosis Azoospermia CFTR CBAVD CUAVD CFTR Renal anomalies Genetic counseling 

Notes

Acknowledgments

Dr. Smita Mahale, Director, ICMR-NIRRH, Mumbai; Dr. Vijay Kulkarni, Consultant Andrologist, ICMR-NIRRH; Mr. Vaibhav Shinde, Technician A, ICMR-NIRRH; and Ms. Aishwarya Bhurke, Project Assistant are sincerely acknowledged.

References

  1. 1.
    Sachdeva K, Saxena R, Majumdar A, Chadha S, Verma IC. Mutation studies in the CFTR gene in Asian Indian subjects with congenital bilateral absence of vas deferens: report of two novel mutations and four novel variants. Genet Test Mol Biomarkers. 2011;15(5):307–12.PubMedCrossRefGoogle Scholar
  2. 2.
    Patat O, Pagin A, Siegfried A, Mitchell V, Chassaing N, Faguer S, et al. Truncating mutations in the adhesion G protein-coupled receptor G2 gene ADGRG2 cause an X-linked congenital bilateral absence of vas deferens. Am J Hum Genet. 2016;99(2):437–42.PubMedPubMedCentralCrossRefGoogle Scholar
  3. 3.
    Bombieri C, Claustres M, De Boeck K, Derichs N, Dodge J, Girodon E, et al. Recommendations for the classification of diseases as CFTR-related disorders. J Cyst Fibros. 2011;10:S86–102.PubMedCrossRefGoogle Scholar
  4. 4.
    Claustres M. Molecular pathology of the CFTR locus in male infertility. Reprod Biomed Online. 2005;10(1):14–41.PubMedCrossRefGoogle Scholar
  5. 5.
    Yu J, Chen Z, Ni Y, Li Z. CFTR mutations in men with congenital bilateral absence of the vas deferens (CBAVD): a systemic review and meta-analysis. Hum Reprod. 2012;27(1):25–35.PubMedPubMedCentralCrossRefGoogle Scholar
  6. 6.
    de Souza DAS, Faucz FR, Pereira-Ferrari L, Sotomaior VS, Raskin S. Congenital bilateral absence of the vas deferens as an atypical form of cystic fibrosis: reproductive implications and genetic counseling. Andrology. 2018;6(1):127–35.PubMedCrossRefGoogle Scholar
  7. 7.
    Carlson BM. Human embryology and developmental biology. Philadelphia: Mosby; 2004. p. 548.Google Scholar
  8. 8.
    Kerem B, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, et al. Identification of the cystic fibrosis gene: genetic analysis. Science. 1989;245(4922):1073–80.PubMedCrossRefGoogle Scholar
  9. 9.
    Daudin M, Bieth E, Bujan L, Massat G, Pontonnier F, Mieusset R. Congenital bilateral absence of the vas deferens: clinical characteristics, biological parameters, cystic fibrosis transmembrane conductance regulator gene mutations, and implications for genetic counseling. Fertil Steril. 2000;74(6):1164–74.PubMedCrossRefGoogle Scholar
  10. 10.
    Claustres M, Guittard C, Bozon D, Chevalier F, Verlingue C, Ferec C, et al. Spectrum of CFTR mutations in cystic fibrosis and in congenital absence of the vas deferens in France. Hum Mutat. 2000;16(2):143–56.PubMedCrossRefGoogle Scholar
  11. 11.
    Hwang K, Yatsenko AN, Jorgez CJ, Mukherjee S, Nalam RL, Matzuk MM, et al. Mendelian genetics of male infertility. Ann N Y Acad Sci. 2010;1214:E1–17.PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    Moskowitz SM, Gibson RL, Effmann EL. Cystic fibrosis lung disease: genetic influences, microbial interactions, and radiological assessment. Pediatr Radiol. 2005;35(8):739–57.PubMedCrossRefGoogle Scholar
  13. 13.
    O’Sullivan BP, Freedman SD. Cystic fibrosis. Lancet. 2009;373(9678):1891–904.PubMedCrossRefGoogle Scholar
  14. 14.
    Ratjen F, Döring G. Cystic fibrosis. Lancet [Internet]. 2003 [cited 2018 Oct 18];361(9358):681–9. Available from: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(03)12567-6/abstract.
  15. 15.
    De Boeck K, Amaral MD. Progress in therapies for cystic fibrosis. Lancet Respir Med. 2016;4(8):662–74.PubMedCrossRefGoogle Scholar
  16. 16.
    Marson FAL, Bertuzzo CS, Ribeiro JD. Classification of CFTR mutation classes. Lancet Respir Med. 2016;4(8):e37–8.PubMedCrossRefGoogle Scholar
  17. 17.
    Cftrscience | Clinician’s guide to CFTR [Internet]. [cited 2018 Oct 21]. Available from: https://www.cftrscience.com/.
  18. 18.
    Gajbhiye R, Gaikwad A. Cystic fibrosis, CFTR gene, and male infertility. In: Singh R, Singh K, editors. Male infertility: understanding, causes and treatment [Internet]. Singapore: Springer Singapore; 2017. p. 131–50. Available from:  https://doi.org/10.1007/978-981-10-4017-7_9.CrossRefGoogle Scholar
  19. 19.
    de Meeus A, Guittard C, Desgeorges M, Carles S, Demaille J, Claustres M. Genetic findings in congenital bilateral aplasia of vas deferens patients and identification of six novel mutatations. Mutations in brief no. 138. Online. Hum Mutat. 1998;11(6):480.PubMedCrossRefGoogle Scholar
  20. 20.
    Groman JD, Hefferon TW, Casals T, Bassas L, Estivill X, Des Georges M, et al. Variation in a repeat sequence determines whether a common variant of the cystic fibrosis transmembrane conductance regulator gene is pathogenic or benign. Am J Hum Genet. 2004;74(1):176–9.PubMedCrossRefGoogle Scholar
  21. 21.
    Xu X, Zheng J, Liao Q, Zhu H, Xie H, Shi H, et al. Meta-analyses of 4 CFTR variants associated with the risk of the congenital bilateral absence of the vas deferens. J Clin Bioinforma. 2014;4:11.PubMedPubMedCentralCrossRefGoogle Scholar
  22. 22.
    Chillón M, Casals T, Mercier B, Bassas L, Lissens W, Silber S, et al. Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. N Engl J Med. 1995;332(22):1475–80.PubMedCrossRefGoogle Scholar
  23. 23.
    Lu S, Cui Y, Li X, Zhang H, Liu J, Kong B, et al. Association of cystic fibrosis transmembrane-conductance regulator gene mutation with negative outcome of intracytoplasmic sperm injection pregnancy in cases of congenital bilateral absence of vas deferens. Fertil Steril. 2014;101(5):1255–60.PubMedCrossRefGoogle Scholar
  24. 24.
    Sharma N, Acharya N, Singh SK, Singh M, Sharma U, Prasad R. Heterogenous spectrum of CFTR gene mutations in Indian patients with congenital absence of vas deferens. Hum Reprod. 2009;24(5):1229–36.PubMedCrossRefGoogle Scholar
  25. 25.
    Gaikwad A, Khan S, Kadam S, Kadam K, Dighe V, Shah R, et al. The CFTR gene mild variants poly-T, TG repeats and M470V detection in Indian men with congenital bilateral absence of vas deferens. Andrologia. 2018;50(2):e12858.CrossRefGoogle Scholar
  26. 26.
    Anzai C, Morokawa N, Okada H, Kamidono S, Eto Y, Yoshimura K. CFTR gene mutations in Japanese individuals with congenital bilateral absence of the vas deferens. J Cyst Fibros. 2003;2(1):14–8.PubMedCrossRefGoogle Scholar
  27. 27.
    Dayangaç D, Erdem H, Yilmaz E, Sahin A, Sohn C, Ozgüç M, et al. Mutations of the CFTR gene in Turkish patients with congenital bilateral absence of the vas deferens. Hum Reprod. 2004;19(5):1094–100.PubMedCrossRefGoogle Scholar
  28. 28.
    Radpour R, Gilani MAS, Gourabi H, Dizaj AV, Mollamohamadi S. Molecular analysis of the IVS8-T splice variant 5T and M470V exon 10 missense polymorphism in Iranian males with congenital bilateral absence of the vas deferens. Mol Hum Reprod. 2006;12(7):469–73.PubMedCrossRefGoogle Scholar
  29. 29.
    Casals T, Bassas L, Egozcue S, Ramos MD, Giménez J, Segura A, et al. Heterogeneity for mutations in the CFTR gene and clinical correlations in patients with congenital absence of the vas deferens. Hum Reprod. 2000;15(7):1476–83.PubMedCrossRefPubMedCentralGoogle Scholar
  30. 30.
    Grangeia A, Niel F, Carvalho F, Fernandes S, Ardalan A, Girodon E, et al. Characterization of cystic fibrosis conductance transmembrane regulator gene mutations and IVS8 poly(T) variants in Portuguese patients with congenital absence of the vas deferens. Hum Reprod. 2004;19(11):2502–8.PubMedCrossRefGoogle Scholar
  31. 31.
    Ratbi I, Legendre M, Niel F, Martin J, Soufir J-C, Izard V, et al. Detection of cystic fibrosis transmembrane conductance regulator (CFTR) gene rearrangements enriches the mutation spectrum in congenital bilateral absence of the vas deferens and impacts on genetic counselling. Hum Reprod. 2007;22(5):1285–91.PubMedCrossRefGoogle Scholar
  32. 32.
    Taulan M, Girardet A, Guittard C, Altieri J-P, Templin C, Beroud C, et al. Large genomic rearrangements in the CFTR gene contribute to CBAVD. BMC Med Genet. 2007;8:22.PubMedPubMedCentralCrossRefGoogle Scholar
  33. 33.
    Trujillano D, Ramos MD, González J, Tornador C, Sotillo F, Escaramis G, et al. Next generation diagnostics of cystic fibrosis and CFTR-related disorders by targeted multiplex high-coverage resequencing of CFTR. J Med Genet. 2013;50(7):455–62.PubMedCrossRefGoogle Scholar
  34. 34.
    Havasi V, Rowe SM, Kolettis PN, Dayangac D, Sahin A, Grangeia A, et al. Association of cystic fibrosis genetic modifiers with congenital bilateral absence of the vas deferens. Fertil Steril. 2010;94(6):2122–7.PubMedPubMedCentralCrossRefGoogle Scholar
  35. 35.
    Obermann H, Wingbermühle A, Münz S, Kirchhoff C. A putative 12-transmembrane domain cotransporter associated with apical membranes of the epididymal duct. J Androl. 2003;24(4):542–56.PubMedCrossRefGoogle Scholar
  36. 36.
    Yang B, Wang J, Zhang W, Pan H, Li T, Liu B, et al. Pathogenic role of ADGRG2 in CBAVD patients replicated in Chinese population. Andrology. 2017;5(5):954–7.PubMedPubMedCentralCrossRefGoogle Scholar
  37. 37.
    Bai S, Du Q, Liu X, Tong Y, Wu B. The detection and significance of cystic fibrosis transmembrane conductance regulator gene promoter mutations in Chinese patients with congenital bilateral absence of the vas deferens. Gene. 2018;672:64–71.PubMedCrossRefGoogle Scholar
  38. 38.
    Krausz C, Riera-Escamilla A. Genetics of male infertility. Nat Rev Urol. 2018;15(6):369–84.PubMedPubMedCentralCrossRefGoogle Scholar
  39. 39.
    Hannema SE, Hughes IA. Regulation of Wolffian duct development. Horm Res Paediatr. 2007;67(3):142–51.CrossRefGoogle Scholar
  40. 40.
    Weiske WH, Sälzler N, Schroeder-Printzen I, Weidner W. Clinical findings in congenital absence of the vasa deferentia. Andrologia. 2000;32(1):13–8.PubMedCrossRefGoogle Scholar
  41. 41.
    Mo B, Garla V, Wyner LM. A case of congenital unilateral absence of the vas deferens. Int Med Case Rep J. 2013;6:21–3.PubMedPubMedCentralCrossRefGoogle Scholar
  42. 42.
    Baydilli N, Gökçe A, Karabulut SY, Ekmekcioglu O. Klinefelter’s syndrome with unilateral absence of vas deferens. Fertil Steril. 2010;94(4):1529.e1–2.CrossRefGoogle Scholar
  43. 43.
    Cai H, Qing X, Niringiyumukiza JD, Zhan X, Mo D, Zhou Y, et al. CFTR variants and renal abnormalities in males with congenital unilateral absence of the vas deferens (CUAVD): a systematic review and meta-analysis of observational studies. Genet Med. 2019;21(4):826.PubMedCrossRefGoogle Scholar
  44. 44.
    Khan ZAJ, Novell JR. A missing vas. J R Soc Med. 2001;94(11):582–3.PubMedPubMedCentralCrossRefGoogle Scholar
  45. 45.
    Akinsal EC, Baydilli N, Imamoglu H, Ekmekcioglu O. Three cases of Klinefelter’s syndrome with unilateral absence of vas deferens. Andrologia. 2017;49(9):e12844.CrossRefGoogle Scholar
  46. 46.
    Gajbhiye R, Kadam K, Khole A, Gaikwad A, Kadam S, Shah R, et al. Cystic fibrosis transmembrane conductance regulator (CFTR) gene abnormalities in Indian males with congenital bilateral absence of vas deferens & renal anomalies. Indian J Med Res. 2016;143(5):616–23.PubMedPubMedCentralCrossRefGoogle Scholar
  47. 47.
    Meschede D, Dworniczak B, Behre HM, Kliesch S, Claustres M, Nieschlag E, et al. CFTR gene mutations in men with bilateral ejaculatory-duct obstruction and anomalies of the seminal vesicles. Am J Hum Genet. 1997;61(5):1200–2.PubMedPubMedCentralCrossRefGoogle Scholar
  48. 48.
    Silber SJ, Nagy Z, Liu J, Tournaye H, Lissens W, Ferec C, et al. Genetics: the use of epididymal and testicular spermatozoa for intracytoplasmic sperm injection: the genetic implications for male infertility. Hum Reprod. 1995;10(8):2031–43.PubMedCrossRefGoogle Scholar
  49. 49.
    Silber SJ, Balmaceda J, Borrero C, Ord T, Asch R. Pregnancy with sperm aspiration from the proximal head of the epididymis: a new treatment for congenital absence of the vas deferens. Fertil Steril. 1988;50(3):525–8.PubMedCrossRefGoogle Scholar
  50. 50.
    Kamal A, Fahmy I, Mansour R, Serour G, Aboulghar M, Ramos L, et al. Does the outcome of ICSI in cases of obstructive azoospermia depend on the origin of the retrieved spermatozoa or the cause of obstruction? A comparative analysis. Fertil Steril. 2010;94(6):2135–40.PubMedCrossRefGoogle Scholar
  51. 51.
    Attardo T, Vicari E, Mollica F, Grazioso C, Burrello N, Garofalo MR, et al. Genetic, andrological and clinical characteristics of patients with congenital bilateral absence of the vas deferens. Int J Androl. 2001;24(2):73–9.PubMedCrossRefGoogle Scholar
  52. 52.
    Llabador MA, Pagin A, Lefebvre-Maunoury C, Marcelli F, Leroy-Martin B, Rigot JM, et al. Congenital bilateral absence of the vas deferens: the impact of spermatogenesis quality on intracytoplasmic sperm injection outcomes in 108 men. Andrology. 2015;3(3):473–80.PubMedCrossRefGoogle Scholar
  53. 53.
    Dialog F and S. Cystic fibrosis genetic testing in congenital bilateral absence of the vas deferens (CBAVD) [Internet]. Fertil Steril Dialog. 2017 [cited 2018 Oct 17]. Available from: https://www.fertstertdialog.com/users/16110-fertility-and-sterility/posts/19299-foyouzi-consider-this.
  54. 54.
    Hantash FM, Milunsky A, Wang Z, Anderson B, Sun W, Anguiano A, et al. A large deletion in the CFTR gene in CBAVD. Genet Med. 2006;8(2):93–5.PubMedCrossRefGoogle Scholar
  55. 55.
    Sharma H, Mavuduru RS, Singh SK, Prasad R. Heterogeneous spectrum of mutations in CFTR gene from Indian patients with congenital absence of the vas deferens and their association with cystic fibrosis genetic modifiers. Mol Hum Reprod. 2014;20(9):827–35.PubMedCrossRefGoogle Scholar
  56. 56.
    Salwan A, Abdelrahman A. Congenital absence of vas deferens and ectopic kidney. Int J Surg Case Rep. 2017;34:90–2.PubMedPubMedCentralCrossRefGoogle Scholar
  57. 57.
    Dörk T, Dworniczak B, Aulehla-Scholz C, Wieczorek D, Böhm I, Mayerova A, et al. Distinct spectrum of CFTR gene mutations in congenital absence of vas deferens. Hum Genet. 1997;100(3–4):365–77.PubMedGoogle Scholar
  58. 58.
    Lissens W, Mahmoud KZ, El-Gindi E, Abdel-Sattar A, Seneca S, Van Steirteghem A, et al. Molecular analysis of the cystic fibrosis gene reveals a high frequency of the intron 8 splice variant 5T in Egyptian males with congenital bilateral absence of the vas deferens. Mol Hum Reprod. 1999;5(1):10–3.PubMedCrossRefGoogle Scholar
  59. 59.
    Wu CC, Hsieh-Li HM, Lin YM, Chiang HS. Cystic fibrosis transmembrane conductance regulator gene screening and clinical correlation in Taiwanese males with congenital bilateral absence of the vas deferens. Hum Reprod. 2004;19(2):250–3.PubMedCrossRefGoogle Scholar
  60. 60.
    Li H, Wen Q, Li H, Zhao L, Zhang X, Wang J, et al. Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) in Chinese patients with congenital bilateral absence of vas deferens. J Cyst Fibros. 2012;11(4):316–23.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Rahul Krishnaji Gajbhiye
    • 1
  • Shagufta Khan
    • 1
  • Rupin Shah
    • 2
  1. 1.Department of Clinical ResearchICMR-National Institute for Research in Reproductive HealthMumbaiIndia
  2. 2.Department of AndrologyLilavati Hospital and Research CentreMumbaiIndia

Personalised recommendations